Publications

Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.

Sarangarajan R. et al, (2021), Journal of racial and ethnic health disparities, 8, 973 - 980

Grozinsky-Glasberg S. et al, (2020), Endocrine-related cancer, 27, R345 - R355

Lines KE. et al, (2020), Endocrine-Related Cancer, 27, 163 - 174

Ford GA. et al, (2020), The journals of gerontology. Series A, Biological sciences and medical sciences, 75, 87 - 88

Fagan V. et al, (2019), Journal of Medicinal Chemistry, 62, 9008 - 9025

Fang H. et al, (2019), Nature Genetics, 51, 1082 - 1091

Wu X. et al, (2019), The Prostate, 79, 1079 - 1089

D'Ascenzio M. et al, (2019), Angewandte Chemie International Edition, 58, 1007 - 1012

Vazquez‐Rodriguez S. et al, (2019), Angewandte Chemie International Edition, 58, 515 - 519

Müller S. et al, (2018), eLife, 7

Al-Hujaily E. et al, (2018), Biomedical Reports

Hunter AJ. et al, (2018), Brain and Neuroscience Advances, 2, 239821281879927 - 239821281879927

Hatch SB. et al, (2017), Epigenetics & Chromatin, 10

Greenhalgh T. et al, (2017), Health Research Policy and Systems, 15

Bradley AR. et al, (2017), Essays in Biochemistry, 61, 495 - 503

Lines KE. et al, (2017), Oncogenesis, 6, e332 - e332

Tumber A. et al, (2017), Cell Chemical Biology, 24, 371 - 380

Carter AJ. et al, (2017), PLOS Biology, 15, e2001387 - e2001387

Zhang C. et al, (2016), Biochemical Pharmacology, 117, 35 - 45

Low E. et al, (2016), ecancermedicalscience, 10